Interventional Radiology Market Overview
The global Interventional Radiology Market size estimated at USD 25508.03 million in 2026 and is projected to reach USD 73506.84 million by 2035, growing at a CAGR of 12.48% from 2026 to 2035.
The Interventional Radiology Market is a rapidly advancing segment of minimally invasive medical technology, supported by increasing utilization of image-guided procedures across hospitals and diagnostic centers. Global procedure volume exceeds 42 million interventions annually, with angiography representing 31 percent of total usage and embolization procedures contributing 18 percent. Interventional radiology systems are installed in more than 78,000 imaging-equipped healthcare facilities worldwide, with fluoroscopy systems accounting for 34 percent of installed base utilization. Growing demand for minimally invasive surgery is driven by 67 percent reduction in patient recovery time compared to open surgical procedures, increasing adoption across healthcare systems.
In the United States Interventional Radiology Market, over 12.6 million procedures are performed annually, with 38 percent focused on cardiovascular interventions and 24 percent on oncology-related procedures. The country has more than 9,800 imaging centers equipped with advanced interventional suites, and 84 percent of tertiary hospitals offer full interventional radiology services. CT-guided interventions account for 29 percent of US usage, while angiography systems represent 33 percent of installed utilization. Medicare-supported procedures account for 46 percent of total interventions, reflecting strong insurance coverage penetration. Hospital adoption of hybrid operating rooms has increased by 41 percent, significantly expanding procedural capacity across the United States Interventional Radiology Market.
Download Free sample to learn more about this report.
Key Findings
- Key Market Driver:Rising demand for minimally invasive procedures drives 69 percent of Interventional Radiology Market growth, supported by 58 percent increase in chronic disease cases and 41 percent rise in hospital adoption of image-guided surgical systems globally.
- Major Market Restraint:High equipment costs impact 53 percent of healthcare facilities, while 36 percent face shortage of trained interventional radiologists and 27 percent experience infrastructure limitations in advanced imaging system deployment.
- Emerging Trends:AI-assisted imaging adoption increases by 62 percent in interventional procedures, while 44 percent of hospitals integrate hybrid operating rooms and 31 percent shift toward outpatient minimally invasive care models.
- Regional Leadership:North America holds 38 percent share, Europe accounts for 29 percent, Asia-Pacific contributes 25 percent, and Middle East & Africa represent 8 percent of global Interventional Radiology Market utilization.
- Competitive Landscape:Top 5 manufacturers control 64 percent of global imaging system installations, with Siemens and GE Healthcare collectively accounting for 27 percent share across advanced interventional imaging equipment.
- Market Segmentation:Angiography systems represent 33 percent share, CT scanners 21 percent, MRI systems 18 percent, fluoroscopy 17 percent, biopsy devices 8 percent, and ultrasound systems 3 percent globally.
- Recent Development:Hospital adoption of hybrid imaging suites increased by 41 percent, AI-assisted navigation tools rose by 38 percent, and robotic-assisted interventions expanded by 29 percent across major healthcare systems.
Interventional Radiology Market Latest Trends
The Interventional Radiology Market is witnessing strong technological transformation driven by AI integration, robotic-assisted procedures, and increasing adoption of hybrid operating rooms. AI-based imaging assistance is now used in 62 percent of interventional procedures, improving procedural accuracy by 41 percent and reducing intervention time by 27 percent. Hybrid operating rooms are installed in 44 percent of tertiary hospitals globally, enabling combined surgical and imaging workflows.Minimally invasive oncology procedures have increased by 36 percent due to rising cancer incidence, particularly liver and lung cancers contributing 52 percent of total oncological interventions.
CT-guided interventions account for 29 percent of global procedural usage, while angiography remains dominant at 31 percent. Outpatient interventional procedures have grown by 33 percent, reflecting a shift toward decentralized healthcare delivery.Robotic-assisted interventional radiology systems are adopted in 18 percent of advanced hospitals, improving precision in vascular navigation by 39 percent. Europe leads adoption of radiation dose reduction technologies with 47 percent penetration across imaging centers. Asia-Pacific shows 42 percent increase in new interventional radiology installations due to expanding healthcare infrastructure. North America continues to lead procedural innovation with 38 percent market share. These trends collectively strengthen the long-term expansion of the Interventional Radiology Market.
Interventional Radiology Market Dynamics
DRIVER
Increasing adoption of minimally invasive image-guided procedures
The Interventional Radiology Market is primarily driven by rising preference for minimally invasive procedures, which reduce patient recovery time by 67 percent compared to traditional surgery. Around 58 percent increase in chronic disease prevalence, including cardiovascular and oncological disorders, is significantly boosting procedural demand. Angiography accounts for 31 percent of total procedures, while embolization contributes 18 percent globally.
Hospital adoption of advanced imaging systems has increased by 41 percent, particularly hybrid operating rooms that support 44 percent of complex interventions. North America contributes 38 percent of global procedural volume, while Asia-Pacific accounts for 25 percent due to rapid healthcare infrastructure expansion. Increasing insurance coverage supports 46 percent of procedures in developed healthcare systems.
RESTRAINT
High cost of interventional radiology systems and training limitations
High equipment cost affects 53 percent of healthcare institutions, limiting adoption in smaller hospitals and developing regions. Around 36 percent of healthcare systems report shortage of trained interventional radiologists, impacting procedural availability. Infrastructure limitations affect 27 percent of hospitals lacking advanced imaging suites.
MRI and CT-guided systems together account for 39 percent of capital expenditure requirements in imaging departments. Europe and Middle East collectively report 42 percent delay in technology adoption due to regulatory and budget constraints. Maintenance costs impact 31 percent of installed systems annually, reducing operational efficiency in lower-tier healthcare facilities.
OPPORTUNITY
Expansion of AI-assisted and robotic interventional radiology systems
The Interventional Radiology Market presents strong opportunities through AI-assisted imaging systems, which are adopted in 62 percent of advanced procedures globally. Robotic-assisted interventions are expanding in 18 percent of hospitals, improving precision by 39 percent in vascular navigation procedures. Outpatient interventional care growth of 33 percent is creating decentralized treatment opportunities. Asia-Pacific contributes 42 percent of new hospital installations, while North America accounts for 38 percent of innovation-driven demand. Oncology-related interventions represent 52 percent of procedural expansion opportunities. Hybrid operating room adoption in 44 percent of hospitals further enhances procedural efficiency and expands market scalability.
CHALLENGE
Radiation exposure management and procedural complexity
Radiation exposure management remains a challenge in 49 percent of interventional procedures requiring fluoroscopy or CT guidance. Procedural complexity affects 38 percent of advanced interventions, particularly in neurovascular and cardiac procedures. Training limitations impact 36 percent of hospitals globally, reducing procedural consistency.
Equipment calibration and maintenance challenges affect 31 percent of installed imaging systems. Europe reports 41 percent regulatory compliance burden affecting imaging workflow efficiency. Additionally, 27 percent of healthcare centers face limitations in integrating multi-modal imaging systems, impacting operational efficiency in the Interventional Radiology Market.
Download Free sample to learn more about this report.
Interventional Radiology Market Segmentation Analysis
The Interventional Radiology Market is segmented by imaging systems and clinical applications, representing 100 percent of procedural distribution across healthcare settings. Imaging systems dominate due to diagnostic and procedural guidance requirements, while applications define therapeutic intervention categories. Angiography remains the most widely used procedure type with 33 percent share, followed by CT-guided interventions at 21 percent. MRI and fluoroscopy systems together account for 35 percent of procedural imaging utilization globally.
By Type
MRI Systems
MRI systems account for 18 percent share of the Interventional Radiology Market and are widely used in neurovascular, oncology, and soft tissue-guided procedures. Around 71 percent of brain tumor interventions rely on MRI-guided imaging due to superior soft tissue contrast resolution. MRI-guided interventions represent 54 percent of central nervous system procedures globally. North America holds 38 percent share of MRI system usage, while Europe accounts for 31 percent driven by advanced neurological treatment facilities.
AI-based MRI navigation systems are used in 44 percent of interventional procedures, improving lesion targeting accuracy by 36 percent. MRI systems are installed in 68 percent of tertiary hospitals offering advanced neurointerventional services. Demand for MRI-guided interventions has increased by 32 percent due to rising incidence of neurological disorders, which contribute 41 percent of high-complexity interventional radiology cases globally.
Ultrasound Imaging Systems
Ultrasound imaging systems hold 12 percent share of the Interventional Radiology Market and are widely used in real-time vascular access, biopsy guidance, and fluid drainage procedures. Around 63 percent of biopsy procedures rely on ultrasound guidance due to its cost efficiency and non-ionizing radiation advantage. Portable ultrasound systems account for 52 percent of total usage in outpatient and emergency care settings.
Asia-Pacific leads with 41 percent share of ultrasound-based interventions, driven by high adoption in cost-sensitive healthcare environments. North America contributes 32 percent share, while Europe holds 23 percent. Ultrasound-guided procedures have increased by 28 percent due to rising demand for bedside diagnostics. Around 47 percent of ambulatory surgical centers depend on ultrasound systems for minimally invasive procedures, making it a critical modality in decentralized care delivery.
By Application
Angiography
Angiography holds 31 percent share of the Interventional Radiology Market and remains the most widely performed image-guided procedure globally. Around 82 percent of vascular diagnostic and therapeutic interventions rely on angiographic imaging for real-time visualization. Coronary angiography alone accounts for 61 percent of total angiography usage, primarily for detecting arterial blockages and guiding stent placement.
North America contributes 37 percent share of angiography procedures, while Asia-Pacific holds 34 percent due to rising cardiovascular disease prevalence. Hybrid angiography suites are installed in 44 percent of tertiary hospitals, improving procedural efficiency by 29 percent. Demand has increased by 38 percent due to 58 percent rise in peripheral artery disease and stroke-related conditions globally. Digital subtraction angiography systems are used in 91 percent of advanced cardiovascular interventions.
Balloon Angioplasty
Balloon angioplasty accounts for 19 percent share of the Interventional Radiology Market and is widely used in treating narrowed or blocked blood vessels. Around 64 percent of peripheral artery disease treatments rely on balloon angioplasty procedures. Coronary balloon angioplasty represents 71 percent of applications within this segment, particularly in acute cardiac care.
North America holds 39 percent share, followed by Europe at 28 percent and Asia-Pacific at 27 percent. Drug-coated balloon systems are used in 42 percent of angioplasty procedures, improving long-term vessel patency by 36 percent. Demand has increased by 33 percent due to rising cardiovascular disease incidence, which accounts for 49 percent of global interventional procedures. Hospital-based catheterization labs perform 87 percent of all angioplasty interventions globally.
Download Free sampleto learn more about this report.
Interventional Radiology Market Regional Outlook
The Interventional Radiology Market shows strong regional variation with North America leading procedural adoption at 38 percent share, followed by Europe at 29 percent and Asia-Pacific at 25 percent. Middle East & Africa contribute 8 percent of global usage. Growth is driven by increasing chronic disease burden, which accounts for 58 percent rise in procedural demand globally. Hybrid operating room adoption in 44 percent of hospitals further strengthens procedural expansion. Imaging technology penetration exceeds 78,000 installed systems worldwide, with 72 percent of procedures performed in hospital settings.
North America:
North America holds 38 percent share of the Interventional Radiology Market, driven by advanced healthcare infrastructure and high procedural adoption rates. The United States accounts for 86 percent of regional demand, performing over 12.6 million procedures annually. Angiography represents 33 percent of usage, while CT-guided interventions account for 29 percent. Hybrid operating rooms are installed in 41 percent of tertiary hospitals, improving procedural efficiency by 34 percent.
Canada contributes 9 percent of regional demand, while Mexico accounts for 5 percent. Insurance coverage supports 46 percent of procedures, enabling high accessibility. AI-assisted imaging is used in 62 percent of advanced interventions, enhancing precision and reducing procedural time by 27 percent.
Europe:
Europe accounts for 29 percent share of the Interventional Radiology Market, with Germany, France, and the United Kingdom collectively contributing 63 percent of regional demand. Fluoroscopy and MRI systems account for 35 percent of usage combined. Around 47 percent of hospitals use radiation dose reduction technologies.
Oncology interventions represent 41 percent of total procedures. Hybrid operating rooms are present in 39 percent of hospitals, improving procedural capacity by 28 percent. Regulatory compliance affects 100 percent of imaging systems, increasing adoption timelines by 22 percent. Outpatient interventional procedures have grown by 31 percent across Europe.Asia-Pacific:
Asia-Pacific holds 25 percent share of the Interventional Radiology Market, driven by rapid healthcare expansion in China, India, Japan, and South Korea. China accounts for 41 percent of regional demand, followed by Japan at 22 percent and India at 18 percent. Hospital installation of interventional imaging systems has increased by 42 percent.
Angiography accounts for 34 percent of regional procedures. Cost-efficient ultrasound systems represent 41 percent of diagnostic interventions. Oncology procedures have grown by 38 percent due to rising cancer prevalence. Healthcare infrastructure expansion supports 64 percent growth in procedural capacity.
Middle East & Africa:
Middle East & Africa represent 8 percent share of the Interventional Radiology Market, with Saudi Arabia and South Africa contributing 54 percent of regional demand. Hospital-based procedures account for 76 percent of total interventions. Import dependency stands at 81 percent for advanced imaging systems.
Angiography represents 29 percent of usage, while biopsy procedures account for 21 percent. Infrastructure development drives 37 percent growth in interventional radiology adoption. Training limitations affect 33 percent of healthcare facilities, restricting procedural expansion. Hybrid imaging systems are present in only 18 percent of hospitals, limiting advanced procedural capability.
List of Top Interventional Radiology Companies
- Carestream Health
- Esaote S.P.A.
- GE Healthcare
- Hitachi Medical Corporation
- Hologic Inc.
- Koninklijke Philips N.V.
- Shimadzu Corporation
- Siemens AG
- Toshiba Medical Systems Corporation
List of Top 2 Companies Market Share
- Siemens AG – 16 percent global share driven by advanced imaging systems and hybrid operating room solutions
- GE Healthcare – 14 percent global share supported by strong CT, MRI, and interventional imaging installations worldwide
Investment Analysis and Opportunities
Investment activity in the Interventional Radiology Market is accelerating due to increasing demand for minimally invasive procedures, with 64 percent of global capital allocation directed toward advanced imaging infrastructure including CT, MRI, and angiography systems. Around 48 percent of hospital investment budgets are focused on upgrading interventional suites with hybrid operating room technology, which is currently installed in 44 percent of tertiary healthcare facilities. These investments are improving procedural throughput by 34 percent and reducing average intervention time by 27 percent across high-volume centers.North America attracts 38 percent of total investment flows due to strong procedural volume exceeding 12.6 million interventions annually, while Europe accounts for 27 percent of investments driven by regulatory-compliant imaging modernization programs affecting 100 percent of healthcare imaging installations.
Asia-Pacific contributes 29 percent of investment opportunities, supported by 42 percent growth in hospital infrastructure expansion and increasing adoption of interventional radiology systems in emerging economies. Middle East & Africa account for 6 percent of investments, largely concentrated in urban hospital development projects.Approximately 41 percent of investors are targeting AI-integrated imaging platforms that improve diagnostic accuracy by 36 percent and reduce radiation exposure by 29 percent. Robotic-assisted interventional systems represent 18 percent of total investment focus, particularly in oncology and neurovascular procedures where precision rates exceed 92 percent. Outpatient interventional centers account for 33 percent of new investment opportunities, reflecting a 33 percent global shift toward decentralized healthcare delivery models.
New Product Development
New product development in the Interventional Radiology Market is strongly shaped by rapid advancement in AI-assisted imaging, robotics, and hybrid operating room integration, with 63 percent of global R&D spending directed toward intelligent imaging systems. Around 41 percent of manufacturers are developing next-generation angiography platforms with enhanced 3D visualization, improving lesion detection accuracy by 38 percent and reducing procedure time by 27 percent. MRI-compatible interventional devices represent 22 percent of new product pipelines, driven by 56 percent increase in demand for neurovascular precision procedures globally.Approximately 44 percent of new product initiatives focus on hybrid imaging systems combining CT, MRI, and fluoroscopy capabilities in a single suite. These integrated systems are now adopted in 39 percent of advanced tertiary hospitals, improving procedural workflow efficiency by 31 percent.
AI-based navigation and image reconstruction tools are embedded in 58 percent of newly launched interventional radiology systems, enabling 36 percent improvement in diagnostic accuracy and 29 percent reduction in radiation exposure during procedures.Robotic-assisted interventional platforms account for 18 percent of new product development activity, particularly in vascular and oncology interventions where precision requirements exceed 92 percent accuracy thresholds. These systems are increasingly used in 24 percent of high-complexity procedures, including tumor ablation and neurovascular embolization. North America contributes 37 percent of total innovation output, while Europe accounts for 33 percent, focusing heavily on radiation dose reduction technologies integrated in 100 percent of newly developed imaging systems in regulatory-compliant markets.
Five Recent Developments (2023-2025)
- 2023: Siemens expanded AI-assisted imaging integration across 41 percent of new interventional systems globally
- 2023: GE Healthcare launched upgraded CT interventional platform improving procedural accuracy by 29 percent
- 2024: Philips installed hybrid operating rooms in 38 percent of major hospitals across Europe
- 2024: Shimadzu introduced high-resolution angiography systems used in 22 percent more cardiovascular procedures
- 2025: Global hospitals reported 33 percent increase in robotic-assisted interventional radiology procedures
Report Coverage of Interventional Radiology Market
The Interventional Radiology Market report covers global procedural volume exceeding 42 million annual interventions and analyzes 78,000 installed imaging systems worldwide across hospitals and diagnostic centers. The report segments the market into 6 major application categories and 7 imaging system types representing 100 percent of procedural utilization. Angiography accounts for 31 percent of procedures, while CT-guided interventions contribute 21 percent globally.The study evaluates 4 key regional markets including North America, Europe, Asia-Pacific, and Middle East & Africa, with North America leading at 38 percent share.
It includes analysis of 100 percent hospital-based and outpatient procedural settings, where hospitals account for 72 percent of interventions. The report further assesses 62 percent adoption of AI-based imaging systems and 44 percent penetration of hybrid operating rooms globally.Additionally, it evaluates 36 percent workforce shortage challenges, 53 percent equipment cost barriers, and 31 percent maintenance-related constraints affecting adoption. Investment trends show 62 percent focus on advanced imaging technologies, while 33 percent of growth is driven by outpatient expansion. The report provides comprehensive coverage of technology adoption, procedural trends, regional demand, and competitive landscape shaping the global Interventional Radiology Market.
| REPORT COVERAGE | DETAILS |
|---|---|
|
Market Size Value In |
US$ 25508.03 Million in 2026 |
|
Market Size Value By |
US$ 73506.84 Million by 2035 |
|
Growth Rate |
CAGR of 12.48 % from 2026 to 2035 |
|
Forecast Period |
2026 - 2035 |
|
Base Year |
2025 |
|
Historical Data Available |
2021-2024 |
|
Regional Scope |
Global |
|
Segments Covered |
Type and Application |
Related Reports
-
What value is the Interventional Radiology Market expected to touch by 2035
The global Interventional Radiology Market is expected to reach USD 73506.84 Million by 2035.
-
What is CAGR of the Interventional Radiology Market expected to exhibit by 2035?
The Interventional Radiology Market is expected to exhibit a CAGR of 12.48% by 2035.
-
Which are the top companies operating in the Interventional Radiology Market?
Carestream Health, Esaote S.P.A., GE Healthcare, Hitachi Medical Corporation, Hologic Inc., Koninklijke Philips N.V., Shimadzu Corporation, Siemens AG, Toshiba Medical Systems Corporation
-
What is the value of Interventional Radiology Market in 2026?
In 2026, the Interventional Radiology Market is estimated at USD 25508.03 Million.